Severe Necrotizing Tracheobronchitis From Panton-Valentine Leukocidin-positive MRSA Pneumonia Complicating Influenza
Michael I Gabrilovich1, Matthew D Huff, Susan M McMillen
1*Division of Pulmonary and Critical Care Medicine, Kettering Health Network, Fort Hamilton Hospital, Hamilton ‡Department of Pathology, Kettering Health Network, Kettering Medical Center, Kettering, OH †IT Department, Diatherix Laboratories, LLC, Huntsville, AL.
No abstract available in PubMed .
More Related Videos
13:45A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
Published on: September 21, 2019
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-III
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
